Cargando…

Corneodesmosin as a potential target of oral squamous cell carcinoma

The relationship between oral squamous cell carcinoma (OSCC) and Corneodesmosin (CDSN) remains unclear. This study aims to explore the correlation between CDSN and the prognosis and survival time of patients with OSCC. METHODS: Bioinformatics were used to identify the hub role of CDSN in the OSCC. A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Di, Yong-Bin, Bao, Yang, Guo, Jie, Liu, Wei, Zhang, Su-Xin, Zhang, Guan-Hua, Li, Tian-Ke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524877/ https://www.ncbi.nlm.nih.gov/pubmed/36181011 http://dx.doi.org/10.1097/MD.0000000000030851

Ejemplares similares

COL11A1 as a potential prognostic target for oral squamous cell carcinoma
por: Di, Yong-Bin, et al.
Publicado: (2022)

Staphylococcus aureus binds to the N-terminal region of corneodesmosin to adhere to the stratum corneum in atopic dermatitis
por: Towell, Aisling M., et al.
Publicado: (2021)

MKI67 an potential oncogene of oral squamous cell carcinoma via the high throughput technology
por: Liu, Zhe-Min, et al.
Publicado: (2022)

Interaction of the Staphylococcus aureus Surface Protein FnBPB with Corneodesmosin Involves Two Distinct, Extremely Strong Bonds
por: Paiva, Telmo O., et al.
Publicado: (2022)

A novel pathogenic variant in the corneodesmosin gene causing generalized inflammatory peeling skin syndrome with marked eosinophilia and trichorrhexis invaginata
por: Gordon, Helen, et al.
Publicado: (2022)

Identification of potential biomarkers and available drugs for oral squamous cell carcinoma
por: Zhang, Zhijun, et al.
Publicado: (2021)

MicroRNA-433 inhibits oral squamous cell carcinoma cells by targeting FAK
por: Wang, Yong-Jian, et al.
Publicado: (2017)

Retraction: MicroRNA-433 inhibits oral squamous cell carcinoma cells by targeting FAK
por: Wang, Yong-Jian, et al.
Publicado: (2022)

MF-094 nanodelivery inhibits oral squamous cell carcinoma by targeting USP30
por: Zhang, Xinyu, et al.
Publicado: (2022)

Identification of potential diagnostic and therapeutic target genes for lung squamous cell carcinoma
por: Zhang, Nana, et al.
Publicado: (2019)

Analysis of the Differentially Expressed Genes Induced by Cisplatin Resistance in Oral Squamous Cell Carcinomas and Their Interaction
por: Wu, Hua-Tao, et al.
Publicado: (2020)

Assessment of Potential Prognostic Value of Peroxiredoxin 1 in Oral Squamous Cell Carcinoma
por: Shen, Yajun, et al.
Publicado: (2021)

Myeloid derived suppressor cells contribute to the malignant progression of oral squamous cell carcinoma
por: Pang, Xin, et al.
Publicado: (2020)

SPP1 and FN1 are significant gene biomarkers of tongue squamous cell carcinoma
por: Xu, Xiao-Liang, et al.
Publicado: (2021)

Interleukin-37 expression and its potential role in oral leukoplakia and oral squamous cell carcinoma
por: Lin, Lin, et al.
Publicado: (2016)

Anti-PD-1 Therapy is Beneficial for the Survival of Patients with Oral Squamous Cell Carcinoma
por: Feng, Liang, et al.
Publicado: (2022)

CD22 is a potential target of CAR-NK cell therapy for esophageal squamous cell carcinoma
por: Liu, Tingdang, et al.
Publicado: (2023)

EGFR and Cortactin: Markers for potential double target therapy in oral squamous cell carcinoma
por: Bissinger, Oliver, et al.
Publicado: (2017)

CircRNAs: A New Chapter in Oral Squamous Cell Carcinoma Biology
por: Fan, Hua-yang, et al.
Publicado: (2020)

Integrated Non-targeted and Targeted Metabolomics Uncovers Amino Acid Markers of Oral Squamous Cell Carcinoma
por: Yang, Xi-Hu, et al.
Publicado: (2020)

The Clinical Potential of Oral Microbiota as a Screening Tool for Oral Squamous Cell Carcinomas
por: Zhou, Xinxuan, et al.
Publicado: (2021)

RAD51 is a poor prognostic marker and a potential therapeutic target for oral squamous cell carcinoma
por: Tsai, Yu-Fen, et al.
Publicado: (2023)

Identification and validation of potential novel biomarkers for oral squamous cell carcinoma
por: Zhang, Mengxue, et al.
Publicado: (2021)

Poor Prognosis of Oral Squamous Cell Carcinoma Correlates With ITGA6
por: Zhang, Churen, et al.
Publicado: (2022)

CD47 as a potential prognostic marker for oral leukoplakia and oral squamous cell carcinoma
por: Ye, Xiaojing, et al.
Publicado: (2018)

Plasma lipid profiling and diagnostic biomarkers for oral squamous cell carcinoma
por: Wang, Lina, et al.
Publicado: (2017)

Therapeutic potential of targeting cell division cycle associated 5 for oral squamous cell carcinoma
por: Tokuzen, Norihiko, et al.
Publicado: (2015)

ErbB4 as a Potential Molecular Target in the Treatment of Esophageal Squamous Cell Cancers
por: Zhao, Ke, et al.
Publicado: (2014)

Expression of CLIC1 as a potential biomarker for oral squamous cell carcinoma: a preliminary study
por: Xu, Ying, et al.
Publicado: (2018)

Targeting HOX-PBX interactions causes death in oral potentially malignant and squamous carcinoma cells but not normal oral keratinocytes
por: Platais, Christopher, et al.
Publicado: (2018)

The preservation and application of the submandibular gland in oral squamous cell carcinoma (STROBE)
por: Zeng, Wen, et al.
Publicado: (2019)

Podoplanin expression in oral potentially malignant disorders and oral squamous cell carcinoma
por: A G, Deepa, et al.
Publicado: (2017)

The Expression and Therapeutic Potential of Checkpoint Kinase 2 in Laryngeal Squamous Cell Carcinoma
por: Tian, Ying, et al.
Publicado: (2020)

Clinicopathological Features of Programmed Cell Death-ligand 1 Expression in Patients with Oral Squamous Cell Carcinoma
por: Cui, Yong-Xin, et al.
Publicado: (2020)

Editorial: Genetics and Molecular Mechanisms of Oral and Esophageal Squamous Cell Carcinoma
por: Qiao, Bin, et al.
Publicado: (2022)

Metronomic Therapy in Oral Squamous Cell Carcinoma
por: Su, Nai-Wen, et al.
Publicado: (2021)

Identification of Candidate Target Genes and Immune Cells in Oral Squamous Cell Carcinoma
por: Xie, Pengfeng, et al.
Publicado: (2021)

Targeted therapy for head and neck squamous cell carcinoma microenvironment
por: Guo, Zhaomeng, et al.
Publicado: (2023)

Clinical Response to Neoadjuvant Immunotherapy Combined with Targeted Therapy and Chemotherapy in Oral Squamous Cell Carcinoma: Experience in Three Patients
por: Tian, Yu, et al.
Publicado: (2022)

miR-146a Overexpression in Oral Squamous Cell Carcinoma Potentiates Cancer Cell Migration and Invasion Possibly via Targeting HTT
por: Wang, Liping, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1qgn29lt4veo6hbp0rb0gb5m1u